STEVEN DUFFIELD

ENDGAME STRATEGIES, LLC · Washington, DC · registered since 2024

Registered · LDAActive

Send proposal →Contact →Claim this profile →

At a glance

Registered since

2024

Senate LDA system

Clients

last 3 years

Filings

4 agencies contacted

Activity

filings by quarter

Works on

Copyright/Patent/Trademark 7 Civil Rights/Civil Liberties 6 Constitution 6 Foreign Relations 3 Law Enforcement/Crime/Criminal Justice 3 Labor Issues/Antitrust/Workplace 3 Health Issues 2

Background

Government experience

Senate Republican Conference

Policy Director); Senate Republican Policy Committee (Deputy Staff Director; Judiciary Policy Analyst/Counsel

Disclosed on LD-2 filings

Senate Republican Conference

Policy Director); Senate Republican Policy Committee (Deputy Staff Director; Chief Counsel; Judiciary Policy Analyst

Disclosed on LD-2 filings

Chief Counsel

Senate Republican Conference; Chief Counsel, Senate Republican Policy Committee; Judiciary Analyst, Senate Republican Policy Committee

Disclosed on LD-2 filings

Chief Counsel

Senate Republican Conference; Chief Counsel, Senate Republican Policy Committee; Judiciary Policy Analyst, Senate Republican Policy Committee

Disclosed on LD-2 filings

Chief Counsel/Policy Director

Senate Republican Conference; Chief Counsel, Senate Republican Policy Committee; Judiciary Policy Analyst/Counsel, Senate Republican Policy Committee

Disclosed on LD-2 filings

Career

ENDGAME STRATEGIES, LLC

Washington, DC

2024 - present

Specific issues

Issues related to the rules governing the Patent Trial and Appeals Board, including both legislative and regulatory proposals. PREVAIL Act, S.2220. Patent Eligibility Restoration Act, S. 2140. General opposition to legislative efforts to weaken the Patent Trial & Appeal Board at the USPTO.

Issues relating to the Hatch Waxman Act and the "skinny labeling" pathway for generic drugs and biologics.

Health Issues · 2024 Q3

PREVAIL Act, S.2220. Patent Eligibility Restoration Act, S. 2140. General opposition to legislative efforts to weaken the Patent Trial & Appeal Board at the USPTO.

Issues relating to civil asset forfeiture, including the FAIR Act (HR 1525).

Constitution · 2024 Q3

Issues relating to civil asset forfeiture, including the FAIR Act (HR 1525). Issues relating to immunity of federal officers

Civil Rights/Civil Liberties · 2024 Q3

Issues relating to the Foreign Sovereign Immunities Act, the Anti-Terrorism Act, and the proper adjudication of civil litigation against foreign powers. S2082/HR4951 - Ensuring Justice for Victims of Terrorism Act.

Constitution · 2024 Q3